[http://dx.doi.org/10.2174/1381612826666210101154118] [PMID: 33388014]
[http://dx.doi.org/10.2174/1381612826666201118103416]
[http://dx.doi.org/10.2174/1874467213666201204154239]
[http://dx.doi.org/10.2174/1381612826666201211121721]
[http://dx.doi.org/10.2174/1381612826666201118112203]
Current Pharmaceutical Design
Title:Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II)
Volume: 27 Issue: 9
Author(s): Mohammad Amjad Kamal and Md. Asaduzzaman Khan
Affiliation:
Export Options
About this article
Cite this article as:
Kamal Amjad Mohammad and Khan Asaduzzaman Md., Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II), Current Pharmaceutical Design 2021; 27 (9) . https://dx.doi.org/10.2174/138161282709210324092345
DOI https://dx.doi.org/10.2174/138161282709210324092345 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space
Current Topics in Medicinal Chemistry Breast Cancer Resistance Protein: A Potential Therapeutic Target for Cancer
Current Drug Targets Ancient Wheat as Promising Nutraceuticals for the Prevention of Chronic and Degenerative Diseases
Current Medicinal Chemistry GIP-Based Therapeutics for Diabetes and Obesity
Current Chemical Biology Prevention and Management of SARS-CoV-2 Infection Among the Health Care Workers
Coronaviruses Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
Current Medicinal Chemistry State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes
Current Medicinal Chemistry Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects
Current Vascular Pharmacology Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Cis-enone Resorcylic Acid Lactones (RALs) as Irreversible Protein Kinase Inhibitors
Current Pharmaceutical Design High Mobility Group Box Protein-1 in HIV-1 Infection: Connecting Microbial Translocation, Cell Death and Immune Activation
Current HIV Research Essential Factors for Successful Virtual Screening
Mini-Reviews in Medicinal Chemistry cGMP-Dependent Protein Kinase in Regulation of the Pulmonary Circulation
Current Respiratory Medicine Reviews Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
Current Medicinal Chemistry Discovery Strategies in a BioPharmaceutical Startup: Maximising your Chances of Success Using Computational Filters
Current Pharmaceutical Design Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation
Current Stem Cell Research & Therapy Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Current Drug Metabolism Computational Approach to Combat COVID-19 Infection: Emerging Tools for Accelerating Drug Research
Current Drug Discovery Technologies Assessing the Performance of 3D Pharmacophore Models in Virtual Screening: How Good are They?
Current Topics in Medicinal Chemistry MicroRNAs in C. elegans Aging: Molecular Insurance for Robustness?
Current Genomics